全文获取类型
收费全文 | 11345篇 |
免费 | 945篇 |
国内免费 | 17篇 |
专业分类
耳鼻咽喉 | 130篇 |
儿科学 | 314篇 |
妇产科学 | 284篇 |
基础医学 | 1531篇 |
口腔科学 | 402篇 |
临床医学 | 1317篇 |
内科学 | 2118篇 |
皮肤病学 | 108篇 |
神经病学 | 964篇 |
特种医学 | 481篇 |
外国民族医学 | 1篇 |
外科学 | 1931篇 |
综合类 | 157篇 |
一般理论 | 7篇 |
预防医学 | 1064篇 |
眼科学 | 261篇 |
药学 | 507篇 |
中国医学 | 7篇 |
肿瘤学 | 723篇 |
出版年
2021年 | 154篇 |
2020年 | 90篇 |
2019年 | 131篇 |
2018年 | 163篇 |
2017年 | 140篇 |
2016年 | 144篇 |
2015年 | 194篇 |
2014年 | 269篇 |
2013年 | 359篇 |
2012年 | 503篇 |
2011年 | 497篇 |
2010年 | 318篇 |
2009年 | 271篇 |
2008年 | 448篇 |
2007年 | 527篇 |
2006年 | 501篇 |
2005年 | 403篇 |
2004年 | 456篇 |
2003年 | 456篇 |
2002年 | 437篇 |
2001年 | 394篇 |
2000年 | 420篇 |
1999年 | 361篇 |
1998年 | 123篇 |
1997年 | 105篇 |
1996年 | 133篇 |
1995年 | 106篇 |
1994年 | 115篇 |
1993年 | 96篇 |
1992年 | 288篇 |
1991年 | 272篇 |
1990年 | 248篇 |
1989年 | 248篇 |
1988年 | 213篇 |
1987年 | 215篇 |
1986年 | 237篇 |
1985年 | 245篇 |
1984年 | 201篇 |
1983年 | 127篇 |
1982年 | 87篇 |
1981年 | 88篇 |
1979年 | 161篇 |
1978年 | 104篇 |
1977年 | 95篇 |
1976年 | 93篇 |
1975年 | 83篇 |
1974年 | 103篇 |
1972年 | 100篇 |
1971年 | 81篇 |
1969年 | 76篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
61.
Hugh Devlin Kety Karayianni Anastasia Mitsea Reinhilde Jacobs Christina Lindh Paul van der Stelt Elizabeth Marjanovic Judith Adams Susan Pavitt Keith Horner 《Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics》2007,104(6):821-828
OBJECTIVES: Measurement of cortical thickness and subjective assessment of cortical porosity on panoramic radiographs are methods previously reported for diagnosing osteoporosis. The aims of this study were to determine the relative efficacy of the mandibular cortical index and cortical width in detecting osteoporosis, both alone and in combination, and to determine the optimal cortical width threshold for referral for additional osteoporosis investigation. STUDY DESIGN: Six hundred seventy-one postmenopausal women 45 to 70 years of age were recruited for this study. They received dual energy x-ray absorptiometry (DXA) scans of the left hip and lumbar spine (L1 to L4), and dental panoramic radiographic examinations of the teeth and jaws. Three observers separately assessed the mandibular cortical width and porosity in the mental foramen region of the mandible. Cortical width was corrected for magnification errors. Chi-squared automatic interaction detection analysis (CHAID) software was used (SPSS AnswerTree, version 3.1, SPSS Inc., Chicago, IL). RESULTS: Chi-squared automatic interaction detection analysis showed that the cortical porosity was a poorer predictor of osteoporosis than mandibular cortical width. For the 3 observers, a mandibular cortical width of <3 mm provided diagnostic odds ratios of 6.51, 6.09, and 8.04. The test is therefore only recommended in triage screening of individuals by using radiographs made for purposes other than osteoporosis. CONCLUSION: When evaluating panoramic radiographs, only those patients with the thinnest mandibular cortices (i.e., <3 mm) should be referred for further osteoporosis investigation. 相似文献
62.
63.
M. L. Jacobs H. M. W. Nathoe P. J. Blankestijn Th. Stijnen R. F. A. Weber 《Clinical endocrinology》1996,44(5):547-553
OBJECTIVE Increased plasma concentrations of GH and increased GH responses to provocative stimuli are reported in patients with poorly controlled type I diabetes and are suggested to be related to complications. Our aim was to investigate GH concentrations in moderately controlled patients.
PATIENTS AND MEASUREMENTS We have investigated IGF-I concentrations and fasting GH concentrations and the response to 1 μg/kg body weight GH-releasing hormone (GHRH) intravenously and/or to 150 μg clonidine intravenously in 77 moderately controlled patients with type I diabetes and in 46 healthy controls.
RESULTS Median HbA1c in the patients was 8.5% (upper level of normal 6.3%). Fasting GH and GH concentrations after the administration of GHRH were not significantly different in patients with type I diabetes compared with normal controls. Fasting and stimulated GH concentrations after the administration of clonidine were significantly higher in the patients, but this could be explained by their lower age and body mass index compared with controls. In controls but not in patients there was a negative correlation between GH and glucose concentrations. IGF-I was significantly lower in patients with diabetes than in controls, even after correction for age, body mass index and sex.
CONCLUSIONS Patients with moderately controlled type I diabetes mellitus have normal baseline and stimulated GH concentrations after the administration of GHRH or clonidine compared with healthy controls, when corrected for age, body mass index and sex. However, these 'normal' GH concentrations must be considered inappropriately high in view of the hyperglycaemia in these patients. The low plasma IGF-I concentrations might be responsible for the GH over-production. 相似文献
PATIENTS AND MEASUREMENTS We have investigated IGF-I concentrations and fasting GH concentrations and the response to 1 μg/kg body weight GH-releasing hormone (GHRH) intravenously and/or to 150 μg clonidine intravenously in 77 moderately controlled patients with type I diabetes and in 46 healthy controls.
RESULTS Median HbA1c in the patients was 8.5% (upper level of normal 6.3%). Fasting GH and GH concentrations after the administration of GHRH were not significantly different in patients with type I diabetes compared with normal controls. Fasting and stimulated GH concentrations after the administration of clonidine were significantly higher in the patients, but this could be explained by their lower age and body mass index compared with controls. In controls but not in patients there was a negative correlation between GH and glucose concentrations. IGF-I was significantly lower in patients with diabetes than in controls, even after correction for age, body mass index and sex.
CONCLUSIONS Patients with moderately controlled type I diabetes mellitus have normal baseline and stimulated GH concentrations after the administration of GHRH or clonidine compared with healthy controls, when corrected for age, body mass index and sex. However, these 'normal' GH concentrations must be considered inappropriately high in view of the hyperglycaemia in these patients. The low plasma IGF-I concentrations might be responsible for the GH over-production. 相似文献
64.
A single-blind randomised trial comparing adrenaline 1.0% with dipivalyl epinephrine (propine) 0.1% in the treatment of open-angle glaucoma and ocular hypertension.
下载免费PDF全文
![点击此处可从《The British journal of ophthalmology》网站下载免费的PDF全文](/ch/ext_images/free.gif)
The results of this single-blind randomised trial comparing adrenaline 1% with dipivalyl epinephrine (Propine) 0.1% confirm that both have a significant effect in lowering the intraocular pressure in patients with open-angle glaucoma and ocular hypertension, but it is generally insufficient to warrant their use as the first line medical treatment of these two conditions. There was no significant difference between the intraocular lowering effect of the two preparations, and 60% of patients receiving Propine and 66% of those receiving adrenaline noted side effects. 相似文献
65.
66.
K Jacobs 《The American journal of occupational therapy》1992,46(5):445-449
Testimony provided by Kemp (1991) before the Subcommittee on Employment Opportunities of the U.S. House of Representatives provided occupational therapists with an open invitation to become involved with the implementation of the ADA: [The] EEOC's [Equal Employment Opportunity Commission's] Office of General Counsel anticipates that a significant portion of the ADA cases will require the use of medical, architectural, ergonomics or vocational specialists. These experts will be called on to provide advice and guidance on general and specific ADA issues and to provide specific advice and testimony in certain cases. (Kemp, 1991 [no page no.]) We need to rally to this opportunity. Occupational therapists' knowledge and understanding of the Americans With Disabilities Act of 1990 is an important component to providing comprehensive services to clients. It is crucial that we as occupational therapists become sophisticated regarding the implications of the ADA and advocate for its implementation for our clients. 相似文献
67.
68.
69.
Inactivation of human synovial fluid phospholipase A2 by the marine natural product, manoalide 总被引:2,自引:0,他引:2
The marine natural product, manoalide (MLD), was investigated to determine if this drug inhibited purified human synovial fluid phospholipase A2 (HSF-PLA2). Utilizing classical Michaelis-Menten kinetics, apparent Km and Vmax values for HSF-PLA2 of 1.34 mM and 0.47 mumol [3H]palmitic acid released/min/mg protein were obtained using dipalmitoylphosphatidylcholine (DPPC) as the substrate, and 38.0 microM and 18.8 mumol [3H]arachidonic acid released/min/mg protein with Escherichia coli as a natural substrate. These kinetic parameters were utilized subsequently to evaluate the inhibitory effects of manoalide on HSF-PLA2. Inhibition of HSF-PLA2 by MLD was concentration and time dependent with IC50 values of 0.2 and 0.02 microM for DPPC and E. coli respectively. Dialysis studies and examination of DPPC or E. coli hydrolysis versus enzyme concentration indicate that MLD is an irreversible inhibitor of HSF-PLA2. Substrate specificity was also examined in the absence and presence of MLD using dipalmitoylphosphatidylethanolamine (DPPE) as a substrate. MLD inhibited the hydrolysis of DPPE (greater than 90% inhibition at 2 microM), and preliminary results indicate that DPPC was more readily hydrolyzed than DPPE under the substrate conditions of the assay. While the cellular source of secreted HSF-PLA2 is unknown, these studies indicate that MLD can inactivate secreted phospholipase A2 isolated from patients with inflammatory joint disease. 相似文献
70.
W. Jacobs 《Der Onkologe》2005,11(3):279-284
Zusammenfassung Versorgungsstrukturen und Versorgungsqualität zu analysieren, sie zu steuern und zu optimieren, gehört mittlerweile zum Kerngeschäft der gesetzlichen Krankenversicherungen (GKV). Ziele von Veränderungen sind mehr Qualität und höhere Effizienz zum Nutzen der Patienten, aber auch aus ökonomischen Gründen. Am Beispiel der Veränderung der Versorgung von Mammakarzinompatientinnen wird die Rolle der Krankenkassen exemplarisch dargestellt. Nach Analyse der Ausgangssituation, die Handlungsbedarf sowohl hinsichtlich der Versorgungsqualität als auch der Patientinnenzufriedenheit ergab, wurde ein Disease-Management-Programm (DMP) Brustkrebs eingeführt, das den ambulanten und stationären Bereich vernetzt und einen Zentrierungsprozess zur Folge hatte. Wesentliche Ziele des DMP Brustkrebs sind: Verbesserung der Qualität des gesamten Behandlungsprozesses durch Zentrierung, Leitlinien- und Evidenzbasierung und starke Vernetzung des ambulanten und stationären Bereichs, Verbesserung der Information und Begleitung der an Brustkrebs erkrankten Frauen und stärkere Mitwirkung der Patientin bei Entscheidungen über die Therapieschritte. 相似文献